Bullpen.News From Edwin Dorsey
Submit an Article

Sector

Macro

Everything our editor has picked under this sector, best first.

36 stories

@Mike10947310 3 clicks

Mike on X

During the Iran dip initially there was a lot of behind the scenes AI progress. And so when there was finally relief — in the form of the initial detente -> MOU — things totally ripped. I feel like with these insane $NVDA and $AVGO guides we are almost in this spot again. Hedge funds have delevered, momo has been historically crushed, Warsh has said a lot of hawkish things, and the next FOMC the market expects a hike. Obviously the big overhang is yields. But it feels to me like for all the discussion of guidance/rates/the yield curve… really the bond market just wants the war to end or at least be paused. I am not so sure that the US has no power to at least have things significantly deescalate when it wants (maybe into midterms). It’s like, we can “lose” a war, but Iran can still recognize that with time its leverage will decrease, its economy will be destroyed further… like it seems a bit naive just to think that because the war is going badly, Iran has no desire to see it wind down. This latest tit for tat for example hasn’t been that crazy. So IF you think that we get some sort of detente, which is really what I think yields need — are we not kind of a coiled spring here and running back a similar setup to when things started ripping?
@BlueDuckCap

BDC on X

From the $TOI Q4 call: “That’s actually a very important question and something that we continue to try to drive clarity with our investors on, which is the MA rate cycle and sort of pressure that you’ve seen health plans and full risk, medical groups that are getting a percent of premium face is actually a tailwind for TOI.Our top line Medicare Advantage reimbursement is not a percent of total premium. It’s not impacted by risk adjustment. In fact, pressure on the top line for payers generally causes them to reach out more proactively when it comes to seeking opportunities to provide great care for their patients and good access while also driving improvement in utilization. And so from that perspective, that actually helps our growth. So we tend to get lumped into some of those macro issues with payers, but I just want to make it very clear that, that is actually probably a good thing for TOI.”